Comind Technologies Ltd. secured $60 million in funding for its optical neuromonitoring device which non-invasively measures ...

In vaccine development, one might think that targeting multiple epitopes increases the likelihood of improving outcomes.

The 2025 Annual Congress of the European Society for Medical Oncology (ESMO) featured a track on tumor-agnostic therapies – the first time such a track has been included at ESMO, or at any major ...

Chugai Pharmaceutical Co. Ltd. and Rani Therapeutics LLC have entered into a collaboration and global license agreement to develop and commercialize an oral product that encompasses Rani’s oral ...

Caught between the rock and the hard place of most-favored nation (MFN) pricing and the threat of a hefty biopharma sector ...

There was a curate’s egg for Sanofi SA from this month’s meeting of the EMA’s Committee for Medicinal Products for Human Use, ...

The full rights to Taysha Gene Therapies Inc.’s lead gene therapy candidate are coming back to the company. In 2022, Astellas ...

Med-tech M&A activity totaled $4.84 billion in September, down slightly from $7.29 billion in July but stronger than August’s ...

Biopharma companies announced $73.38 billion in deals from 240 transactions during the third quarter (Q3) of 2025, bringing ...

The U.S. FDA named the first nine recipients of the recently unveiled commissioner’s national priority voucher (CNPV) program ...

Writing in the Journal of Medicinal Chemistry, researchers from Shenzhen University Medical School and collaborating ...

Aicuris Anti-Infective Cures AG is preparing to file for U.S. FDA approval after reporting positive phase III results for ...